O n e hundred and forty-four Fischer 344 rats and 144 B6C3F1 mice (72/sex/ species) were fed either a control diet o r a diet containing 300, 600, 1200, 2400 or 3600 ppm sulfamethazine for 90 days. They were then necropsied and tissue specimens were evaluated for pathological changes by light and transmission electron microscopy. No gross or light microscopic lesions related to sulfamethazine administration were evident in the mice. Thyroid gland enlargement was evident at necropsy in one half of the rats (12 of 24) which received the 3600 ppm level of sulfamethazine and in 1 of 24 rats fed the 2400 ppm level. By light microscopy, thyroid gland hyperplasia was evident-in rats which received all 5 dose levels of the compound, but this change was more pronounced and more frequent in those animals administered the higher concentrations. This thyroid hyperplasia was observed in rats of both sexes, but with greater incidence in males than in females, among the groups receiving the lower concentrations of compound. Ultrastructural changes included markedly dilated rough endoplasmic reticulum, altered microvilli, and diminished colloid droplets involving the thyroid follicular cells and compartmentalization of colloid within the follicular lumina.
INTRODUCTION
Sulfamethazine or 4-amino-N-(4,&dimethyl-2-pyrimidinyl) benzenesulfonamide is an antibacterial drug belonging to the chemical class of sulfonamides used therapeutically and prophylactically in a variety of domestic animals and fowl, including swine, horses, cattle, sheep, dogs, cats,&hickens and turkeys. It is one of the most ec'ohomical and effective drugs available for the prevention and control of atrophic rhinitis in swine .
The problem of sulfonamide residues in animal tissues for human consumption attracted public attention when residues were discovered in swine kidney, liver and muscle, exceeding the 0.1 ppm tolerance level set by the Federal Drug Administration (FDA) (Federal Register Oct. 23,1970) . In 1978, the withdrawal time for sulfamethazine administration to swine was changed from 7 to 15 days to help alleviate body burden (Federal Register Dec. 9,1977 ). However, it seems possible for swine receiving non-medicated feeds, to have violative tissue residues resulting from fecal and urine contamination when housed in facilities previously occupied by animals receiving the drug. The possibility would therefore exist for human exposure to sulfamethazine through ingestion of pork or other animal tissues containing these high residues. TOXICOLOGIC PATHOLOGY In view of earlier reports of thyroid gland hyperplasia and tumor formation (I, 2, 3, 4) and testicular hypoplasia (5) in rodents resulting from sulfonamide administration, and because of the potential for human exposure via the food chain, a comprehensive toxicological evaluation of sulfamethazine was initiated at the National Center for Toxicological Research (NCTR) at the request of FDA's Bureau of Drugs and Bureau of Veterinary Medicine. The material presented here represents the findings from the subchronic (maximum tolerated dose) phase of this evaluation.
METHODS
One hundred and forty-four Fischer 344 rats and 144 (C57BL/6N X C3H/HeN)F1 (BSCSF,) mice were administered sulfamethazine in the diet continuously for 00 days beginning at approximately 21 days of age. Rats and mice were randomized to 5 treatment groups and 1 untreated control group consisting of 1 2 animals per sex per group. Levels of sulfamethazine for both species were 0, 300, 600, 1200, 2400 and 3600 ppm provided in the diet ad libitum. Chemical analysis was performed on each batch of feed for each level prior to administration to assure proper concentration of the drug. Water was provided ad libitum. Animals were housed 3 rats/cage and 4 mice/cage and were observed daily. No significant signs of clinical toxicity were observed.
At the end of the 90-day sulfamethazine administration period, all rats and mice were sacrificed with carbon dioxide administration and necropsied. Approximately 45 selected tissue specimens along with any gross lesions from each animal were collected in Bouin's solution (6, 7). Maxillae (nasal turbinates) were collected in decalcifying solution (Cal Ex 11, Fisher Scientific). After fixation, tissues were trimmed, and embedded in paraffin blocks. Paraffin sections were cut a! 5 pm, stained on an automatic stainer d i t h hematoxylin and eosin and examined micro-' scopically. Selected tissues were stained with periodic acid-Schiff and Masson's trichrome techniques.
Selected tissues for transmission electron microscopy were sectioned into small blocks and fixed in 4% glutaraldehyde with 0.1 M phosphate buffer (pH 7.2-7.4) at 4°C for 24 hours. The tissues were rinsed in 0.2 M Dhos-at 10 minutes each and fixed in 1% osmium tetroxide in 0.1 M phosphate buffer (pH 7.2-7.4) at 4°C for 1 hour. The tissues were dehydrated, and embedded in an Epon/Araldite mixture. Sections were cut with diamond knives on ultramicrotomes, stained with uranyl acetate and lead citrate, and examined with a Philips EM 201 electron microscope.
RESULTS

Mice.
No gross or microscopic lesions which were considered related to administration of sulfamethazine were observed in any of the mice examined. The changes observed were those considered to be of normal background incidence for mice of this age and strain, and they occurred uniformly in mice from control and treated groups.
Rats. Necropsy findings: Thyroid gland enlargement was evident in 1 (a female) of 24 rats at the 2400 ppm level and in 1 2 (8 male, 4 female) of 24 rats at the 3600 ppm level (Figure 1 ). Other gross lesions occurred uniformly among control and treated groups and were considered spontaneous. Light microscopy: Thyroid gland hyperplasia was the only visible microscopic change that could be attributed to administration of sulfamethazine. 0 1 her lesions observed were considered spontaneous for rats of this age and strain, and they were seen uniformly in rats from control and treated groups.
The incidence oft hyroid gland hyperplasia increased in a dose-related manner in rats of both sexes, but the increase occurred at lower dose levels in male rats than in females (Figure 2) . The incidence was 100 percent of both male and female rats fed the highest (3600 ppm) level. Due to problems encountered in collection of thyroid glands for histological processing, this tissue was not available for microscopic evaluation from all animals necropsied.
The thyroid changes denoted as "hyperplasia" included deviations from normal in individual follicular cells as well as changes in follicular architecture and the appearance of colloid (Figure 3) . When viewed at low magnification, the hyperplastic glands contained irregularly 'shaped follicles with narrowed and often slit-like lumina. The follicular epithelium was often convoluted, and it occasionally formed papillary structures which projected into the follicular lumina. These changes were usually more pronounced within the more central portions while the follicles at the periphery appeared more dilated with less tortuous epithelium. At higher magnification, the follicular cells appeared distinctly columnar in contrast to the low cuboidal or flattened epithelium observed in the glands of control rats. The cell cytoplasm was finely vacuolated and more acidophilic than normal and the nuclei were spherical in shape when compared to the normal ovoid nuclei and occupied a basilar position lvithin the cell. This increased cellularity was accompanied by a reduction of colloid material, and the remaining colloid often contained clear spherical vacuoles, approximately 5-20 pm in diameter, which appeared more numerous in the region immediately overlying the epithelium. Many of the glands from treated rats also contained an increased degree of vascularity when compared with controls.
Electron microscopy: Electron microscopic studies were conducted on thyroid glands of rats from the control and highest dosage level (3600 ppm) sulfamethazine-treated group. The most obvious ultrastructural changes observed in the thyroid follicular cells of treated rats when compared with controls were the noticeable increase in cell size and the marked dilation of rough endoplasmic reticulum (Figures 4 and 5 ). Many cells were distinctly columnar in shape with the nucleus situated in the basilar portion. Mitochondria and structures resembling lysosomes were compressed among the dilated cisternae of the endoplasmic reticulum, together with increased numbers of dense secretory granules aggregated in the extreme apical regions. Resorbed colloid droplets appeared reduced in number when compared with controls. Microvilli often appeared blunted or fused into continuous membrane bound zones of moderately coarse granularity (Figure 6) , and material which appeared to be fragments of these structures was occasionally extruded into the lumen (Figure 7 ). Follicular cell nuclei from treated rats were larger and more spherical than those from controls, and contained denser and more coarsely granular chromatin and increased numbers of nucleoli (Figure 4) . The colloid material was often compartmentalized into several irregularly shaped zones separated by thin electron-lucent bands. These different compartments contained colloid of varying densities (Figure 8 ) .
DISCUSSION
The absence of gross and microscopic lesions in mice from this study contrast with finding of earlier workers (2) in which gross enlargement and microscopic hyperplasia were observed in mice fed sulfaguanidine, sulfapyridine and sulfathiazole. This disparity could be the result of a higher tolerance of mice to the induction of thyroid hyperplasia by sulfamethazine when compared with other sulfonamides or that sulfamethazine is not toxic to mice at any dose level. It should also be noted that sulfonamide levels of from 1% to 3% in diet were administered to mice in the previous study whereas the highest dietary level in the present experiment was 3600 ppm or 0.36%. It is conceivable that if higher dietary levels of sulfamethazine had been administered in our study, noticeable thyroid changes could have resulted.
The absence of atrophic changes involving the testes and accessory sex glands of rats in the present study differ from findings in an earlier investigation (5). The previous study employed rats of an inbred stock with animals receiving 0.2% sulfamethazine in the diet for 35 to 42 days. This dietary concentration is slightly less than the second highest level in the present study. Although the possibility of a variation in strain susceptibility cannot be totally excluded, this idea seemed unlikely and the disparity in findings cannot be readily explained. It is hoped that the chronic phase of the present study can shed more light on this issue.
Gross and light microscopic thyroid changes in rats from this experiment coincide with those reported by previous investigators employing other sulfonamides (1, 2, 3, 4, 8) . Thyroid enlargement noted at necropsy was not verified by weighing of the organs and is intended to serve only as a rough indicator of thryoid involvement. It does, however, point out the degree of involvement at the higher dietary dosage levels when compared to those of low and intermediate concentra-tions. Whereas thyroid hyperplasia was evident by light microscopy at the lower and intermediate levels, especially in males, the detection of grossly visible changes only at the higher levels illustrates the more extensive involvement at these higher concentrations and indicates a dose-dependent response.
Light microscopic evaluation of thyroid hyperplasia was, as with the observations recorded at necropsy, an interpretive one and degrees of severity were apparent. Glands recorded as hyperplastic were those which could, with a reasonable degree of certainty, be characterized as having at least two of the following features: 1) columnar shaped follicular cells, 2) papillary projections of follicular cells into the follicular lumina, 3) irregular or slit-like follicular lumina, 4) marked vacuolation or diminution of colloid. As mentioned previously, papillary follicular epithelium was more prominent toward the central portion of the glands while follicles at the gland periphery tended to enlarge in diameter. This observation was ascribed to the increase in number and size of follicular cells with compression of the more centrally located follicles by the surrounding parenchyma, thus preventing the dilation and enlargement in the marginally situated follicles. While increased vascularity was evident in many hyperplastic glands, this change was considered somewhat equivocal in view of the variation in agonal pooling of blood in glands of both control and treated rats. Whereas no reference was found to a sex difference in thyroid changes in previous studies of rats fed sulfonamides, the findings depicted in Figure 2 suggest that male rats have a lower tolerance to induction of thyroid hyperplasia than females. In males, the change was noted in 44.4% of examined glands from rats fed the 600 ppm level and in 66.7% of those fed 1200 ppm; in females the incidence was 0.0% and 9.1% at the same levels, respectively. Both males and females, however, had a sustained increase in incidence of the lesion as the dose level of the compound increased.
Earlier investigators established that the goitrogenic action of sulfonamides is mediated through the adenohypophysis (1, 2, 3) . Diminished blood levels of thyroid hormone result in the absence of a negative feedback on thyrotropic hormone production by the anterior pituitary gland, and continued thy-roid gland stimulation and resultant hyperplasia occurs. It is possible that either defective thyroglobulin synthesis or abnormal reabsorption of thyroglobulin by the follicular cell could result in this sequence of events. Defective synthesis is supported by the ultrastructural evidence of abnormally appearing colloid material within the follicular lumina while faulty reabsorption is suggested by the demonstration of altered follicular cell microvilli and reduced numbers of resorbed colloid droplets. A less plausible explanation in view of these ultrastructural findings is that the abnormal hydrolysis of thyroglobulin could result in insufficient formation of active hormone.
Because of their structural similarity to known carcinogenic agents of the aniline dye group, sulfonamides attracted the attention of earlier investigators (9, 10). Injections of sulfanilamide were shown to induce spindle cell sarcomas at the site of injection in both mice and rats (lo, 11), and injection site sarcomas were induced in rats by injecting sulfapyridine .(lo). Later studies employing the injection or implantation of a variety of sulfonamides demonstrated the induction of several types of neoplasia including renal adenocarcinomas, lymphosarcomas and spindle cell sarcomas in Wistar rats (12). Thyroid hyperplasia which progressed to tumor formation with lung metastasis was produced in rats following long term oral administration of sulfamethoxazole, although thyroid gland changes were not induced in monkeys following a similar treatment regimen (1).
The results reported here reaffirm the action of the sulfonamide group of drugs in the induction of thyroid gland hyperplasia in the rat and support the need for a chronic bioassay to determine their long-term effect at lower dosage levels. The chronic phase of the NCTR sulfamethazine evaluation is cur-rently underway utilizing F344 rats and B6C3F, mice in a lifetime feeding study with lower dietary levels bf compound than were used in the subchronic study. It is felt that the results of the chronic study will help to elucidate the role of these compounds in the induction of neoplasia and chronic toxicity in these two species and serve as an indicator of their potential hazard resulting from chronic human exposure.
